Report shows U.S. cancer deaths on the decline
the ONA take:
According to a new report published in the Journal of the National Cancer Institute, there has been a continuing decline in cancer deaths in the United States between 2002 and 2011. During that period, the overall cancer death rate fell an average 1.5% per year for men, women, and children. Specifically, cancer death decreased 1.8% per year among men, 1.4% per year among women, and about 2% per year for children.
The report also found that the rate of new cancer cases also decreased an average 0.5% per year during those years. However, the report found that cancer rates are increasing for kidney, liver, mouth and throat, and thyroid cancer.
"These numbers reflect a combination of factors that include prevention, early detection and improved treatment," said report co-author Ahmedin Jemal, vice president of surveillance research for the American Cancer Society.
Colon and breast cancer deaths are declining due to prevention efforts, while lower rates of lung cancer deaths are due to fewer people smoking. Prostate cancer rates are also declining, but experts are not sure why.
There has been a continuing decline in cancer deaths in the United States between 2002 and 2011.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|